The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
The approval follows strong results from Roche’s phase II NOBILITY and phase III REGENCY studies
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Expands bioprocessing footprint across Asia
It's a development that marks a potential breakthrough for people living with the rare and debilitating disease Duchenne muscular dystrophy (DMD)
It's an acquisition that aims at forming one of the US's largest oncology trial networks
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Patients can now get the starting 2.5 mg dose for $299 per month
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
Subscribe To Our Newsletter & Stay Updated
